Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Background: Bilastine, a novel non-sedating second-generation H1 antihistamine, has been approved in most European countries since 2010. This study aimed to evaluate the superiority of bilastine over placebo in Japanese patients with perennial allergic rhinitis (PAR). Methods: This randomized, doubl...

Full description

Bibliographic Details
Main Authors: Kimihiro Okubo, Minoru Gotoh, Mikiya Asako, Yasuyuki Nomura, Michinori Togawa, Akihiro Saito, Takayuki Honda, Yoshihiro Ohashi
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Allergology International
Subjects:
Bilastine
Fexofenadine
H1-antihistamine
Perennial allergic rhinitis
Total nasal symptom score
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893016300855

Internet

http://www.sciencedirect.com/science/article/pii/S1323893016300855

Similar Items